Historical record - last NADAC publication: 2/21/2018
Product Information
RELION NOVOLIN 70-30 VIAL is a brand product labeled by Novo Nordisk, priced at $13.4759 per ML under NDC 00169183702. Its NADAC has been published 262 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Novo NordiskNDC
00169183702
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Last Updated
2/21/2018
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA019991On Market Since
6/25/1991
Pharmacological Classes
Price Statistics
The NADAC for RELION NOVOLIN 70-30 VIAL has been published 262 times since Nov 28, 2013, and over the history we have for it it has risen 67.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.4759 per ML |
|---|---|
| All-time high | $13.4759 (Nov 28, 2018) |
| All-time low | $8.0708 (Nov 28, 2013) |
| Median price | $12.4714 |
| Average price | $12.0548 |
| Largest weekly change | +9.9% (Nov 26, 2014) |
| Weeks tracked | 262 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RELION NOVOLIN 70-30 VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RELION NOVOLIN 70-30 VIAL, manufactured by Novo Nordisk, is $13.4759 per ML (NDC 00169183702), effective Nov 28, 2018.
How has the price of RELION NOVOLIN 70-30 VIAL changed over time?
Over the history we have for it, the NADAC for RELION NOVOLIN 70-30 VIAL has risen 67.0%. It has been tracked across 262 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RELION NOVOLIN 70-30 VIAL?
Since Nov 28, 2013, the NADAC for RELION NOVOLIN 70-30 VIAL has ranged from a low of $8.0708 (Nov 28, 2013) to a high of $13.4759 (Nov 28, 2018), with a median of $12.4714 per ML.
Are there cheaper alternatives to RELION NOVOLIN 70-30 VIAL?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NOVOLIN N 100 UNIT/ML VIAL, is $4.6222 per ML — about 66% below RELION NOVOLIN 70-30 VIAL.
Who manufactures RELION NOVOLIN 70-30 VIAL?
RELION NOVOLIN 70-30 VIAL (NDC 00169183702) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification